Cargando…

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis

Critical Gram-negative pathogens, like Pseudomonas, Stenotrophomonas and Burkholderia, have become resistant to most antibiotics. Complex resistance profiles together with synergistic interactions between these organisms increase the likelihood of treatment failure in distinct infection settings, fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadeřábková, Nikol, Furniss, R. Christopher D., Maslova, Evgenia, Eisaiankhongi, Lara, Bernal, Patricia, Filloux, Alain, Landeta, Cristina, Gonzalez, Diego, McCarthy, Ronan R., Mavridou, Despoina A.I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418187/ https://www.ncbi.nlm.nih.gov/pubmed/37577508 http://dx.doi.org/10.1101/2023.08.02.551661

Ejemplares similares

Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding
por: Furniss, R Christopher D, et al.
Publicado: (2022)

Burns and biofilms: priority pathogens and in vivo models
por: Maslova, Evgenia, et al.
Publicado: (2021)

The biogenesis of β-lactamase enzymes
por: Kaderabkova, Nikol, et al.
Publicado: (2022)

Disrupting iron homeostasis can potentiate colistin activity and overcome colistin resistance mechanisms in Gram-Negative Bacteria
por: Gadar, Kavita, et al.
Publicado: (2023)

A novel stabilization mechanism for the type VI secretion system sheath
por: Bernal, Patricia, et al.
Publicado: (2021)

Using the Galleria mellonella burn wound and infection model to identify and characterize potential wound probiotics
por: Maslova, Evgenia, et al.
Publicado: (2023)

Artificial sweeteners inhibit multidrug‐resistant pathogen growth and potentiate antibiotic activity
por: de Dios, Rubén, et al.
Publicado: (2022)

Detection of Colistin Resistance in Escherichia coli by Use of the MALDI Biotyper Sirius Mass Spectrometry System
por: Furniss, R. Christopher D., et al.
Publicado: (2019)

The Breadth and Molecular Basis of Hcp-Driven Type VI Secretion System Effector Delivery
por: Howard, Sophie A., et al.
Publicado: (2021)

Colistin resistance in Escherichia coli confers protection of the cytoplasmic but not outer membrane from the polymyxin antibiotic
por: Humphrey, Madeleine, et al.
Publicado: (2021)

Identification of Tse8 as a Type VI secretion system toxin from Pseudomonas aeruginosa that targets the bacterial transamidosome to inhibit protein synthesis in prey cells
por: Nolan, Laura M., et al.
Publicado: (2021)

Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future
por: Perikleous, Evanthia P., et al.
Publicado: (2023)

An Invertebrate Burn Wound Model That Recapitulates the Hallmarks of Burn Trauma and Infection Seen in Mammalian Models
por: Maslova, Evgenia, et al.
Publicado: (2020)

Coexistence of cystic fibrosis and phenylketonuria.
por: Greeves, L. G., et al.
Publicado: (1997)

Direct detection of lipid A on intact Gram-negative bacteria by MALDI-TOF mass spectrometry
por: Larrouy-Maumus, Gerald, et al.
Publicado: (2016)

The clue is in the lipid A: Rapid detection of colistin resistance
por: Furniss, R. Christopher D., et al.
Publicado: (2020)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Cyclic di‐GMP inactivates T6SS and T4SS activity in Agrobacterium tumefaciens
por: McCarthy, Ronan R., et al.
Publicado: (2019)

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
por: Roehmel, Jobst, et al.
Publicado: (2014)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis
por: Fouhy, F., et al.
Publicado: (2017)

Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities
por: Nichols, Dave P., et al.
Publicado: (2019)

Use of inhaled antibiotics among Danish patients with cystic fibrosis
por: Møller, Rikke, et al.
Publicado: (2022)

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
por: Vandeplassche, Eva, et al.
Publicado: (2019)

Cyclic-di-GMP regulates lipopolysaccharide modification and contributes to Pseudomonas aeruginosa immune evasion
por: McCarthy, Ronan R., et al.
Publicado: (2017)

Nebulizer Care and Inhalation Technique in Children with Cystic Fibrosis
por: Petrocheilou, Argyri, et al.
Publicado: (2020)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
por: Taccetti, Giovanni, et al.
Publicado: (2021)

The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects
por: Van den Bossche, Sara, et al.
Publicado: (2021)

A new future for patients with cystic fibrosis
por: Pullen, Lara C.
Publicado: (2020)

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
por: Hurley, M.N., et al.
Publicado: (2012)

Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
por: Ramsey, Mitchell L, et al.
Publicado: (2022)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Plasma membrane profiling during enterohemorrhagic E. coli infection reveals that the metalloprotease StcE cleaves CD55 from host epithelial surfaces
por: Furniss, R. Christopher D., et al.
Publicado: (2018)

Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane
por: Sabnis, Akshay, et al.
Publicado: (2021)

Costs and benefits of provocation in bacterial warfare
por: Gonzalez, Diego, et al.
Publicado: (2018)

Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation
por: Ma, Shuren, et al.
Publicado: (2019)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Pseudomonas aeruginosa is oxygen-deprived during infection in cystic fibrosis lungs, reducing the effectiveness of antibiotics
por: Martin, Lois W, et al.
Publicado: (2023)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qf7h1d3811pamk9u0hs2aa8aqq